Company Filing History:
10 out of 10 
1 out of 1 
8 out of 832,912 Years Active: 1999-2025
Title: Ivan Bergstein: Innovator in Cancer Treatment
Introduction
Ivan Bergstein is a noteworthy inventor based in New York, NY, with a remarkable portfolio consisting of 19 patents. His work primarily focuses on innovative therapies for cancer treatment, significantly impacting the medical field.
Latest Patents
Among his latest inventions, Bergstein has developed a combination therapy method for treating myeloproliferative neoplasms, utilizing a diphtheria toxin-human interleukin-3 conjugate in conjunction with other agents. This invention aims to enhance treatment efficacy for patients suffering from these types of cancers. Furthermore, he has also created cancer stem cell targeted cancer vaccines, providing comprehensive methods for treating and vaccinating against cancer. These vaccines include detailed regimens that combine various immunomodulatory agents and peptides, tailored to specific patient populations.
Career Highlights
Throughout his career, Ivan Bergstein has played a pivotal role in advancing cancer research and treatment methodologies. His contributions have established him as a leading figure in the field of oncology, leveraging his expertise to develop groundbreaking therapies that address unmet medical needs.
Collaborations
Bergstein has collaborated with esteemed colleagues, including Thomas P. Cirrito and Christopher Brooks. These partnerships have fostered an environment of innovation, enabling the development of effective treatment options for cancer patients.
Conclusion
Ivan Bergstein continues to be an influential inventor whose work has the potential to transform cancer treatment. With numerous patents to his name and a dedication to advancing medical science, his contributions are highly regarded within the scientific community.